I noticed one of the more recent reports from an analyst, was assuming revenues next year of USD85 million, that seeems like an extremely low ball figure. Assuming USD 1.25 million weekly sales by week 52 this year, as it looks like we're headed for, we just need 1% weekly growth to reach that USD85 million for 2017. 2% will get us to USD112 million for 2018, considering IBS-C approval is coming up in the beginning of the year that seems more than fair, assuming that 2% continues that will take us to USD300 million in 2019. However I think we will see higher numbers for both 2018 and thereby more than USD300 million for 2019.
